MATSUO; Masafumi

Patent Applications and Registrations

Patent applications and USPTO patent grants for MATSUO; Masafumi.The latest application filed is for "nucleic acid drug suppressing production of myostatin gene mrna".

Company Profile

1.26.22

MATSUO; Masafumi - Hyogo JP
Matsuo; Masafumi - Kobe JP
Matsuo; Masafumi - Kobe-shi JP
Matsuo; Masafumi - Kanagawa JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nucleic Acid Drug Suppressing Production Of Myostatin Gene Mrna App 20220220478 - MATSUO; Masafumi ; et al.	2022-07-14
Inhibition Of Myostatin Signal By Myostatin Splice Variant-derived Protein And Utilization Thereof App 20220135637 - MATSUO; Masafumi ; et al.	2022-05-05
Myocardial Dysfunction Therapeutic Agent App 20210207136 - MATSUO; Masafumi ; et al.	2021-07-08
Therapeutic Agent For Glycogen Storage Disease Type Ia App 20200407394 - KOIZUMI; Makoto ; et al.	2020-12-31
Nucleic acid drug for inducing skipping of variant exon of CD44 gene and increasing expression of normal type CD44 mRNA Grant 10,174,319 - Matsuo , et al. J	2019-01-08
ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursors Grant 9,657,049 - Matsuo , et al. May 23, 2	2017-05-23
ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursors Grant 9,657,050 - Matsuo , et al. May 23, 2	2017-05-23
Nucleic Acid Drug For Inducing Skipping Of Variant Exon Of Cd44 Gene And Increasing Expression Of Normal Type Cd44 Mrna App 20170137810 - MATSUO; Masafumi ; et al.	2017-05-18
Readthrough inducing agent and drug for treating genetic disease caused by nonsense mutation Grant 9,358,246 - Matsuda , et al. June 7, 2	2016-06-07
ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursors Grant 9,243,026 - Matsuo , et al. January 26, 2	2016-01-26
Prophylactic or ameliorating agent for genetic diseases Grant 9,241,929 - Hagiwara , et al. January 26, 2	2016-01-26
ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF mRNA PRECURSORS App 20160002636 - MATSUO; Masafumi ; et al.	2016-01-07
Readthrough Inducing Agent and Drug for Treating Genetic Disease Caused by Nonsense Mutation App 20150005249 - Matsuda; Ryoichi ; et al.	2015-01-01
ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF mRNA PRECURSORS App 20140316123 - Matsuo; Masafumi ; et al.	2014-10-23
Self-diagnosis system and test circuit determination method Grant 8,719,650 - Matsuo May 6, 2	2014-05-06
ENA nucleic acid drugs modifying splicing in mRNA precursor Grant 8,624,019 - Matsuo , et al. January 7, 2	2014-01-07
Prophylactic or Ameliorating Agent for Genetic Diseases App 20130102644 - Hagiwara; Masatoshi ; et al.	2013-04-25
ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF mRNA PRECURSORS App 20130090465 - MATSUO; Masafumi ; et al.	2013-04-11
Readthrough Inducing Agent and Drug for Treating Genetic Disease Caused by Nonsense Mutation App 20130005953 - MATSUDA; Ryoichi ; et al.	2013-01-03
Self-diagnosis System And Test Circuit Determination Method App 20110264972 - MATSUO; Masafumi	2011-10-27
ENA nucleic acid drugs modifying splicing in mRNA precursor Grant 7,902,160 - Matsuo , et al. March 8, 2	2011-03-08
ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR App 20110046360 - MATSUO; Masafumi ; et al.	2011-02-24
Ena nucleic acid drugs modifying splicing in mrna precursor App 20070082861 - Matsuo; Masafumi ; et al.	2007-04-12
Pharmaceutical composition for treatment of Duchenne muscular dystrophy Grant 6,727,355 - Matsuo , et al. April 27, 2	2004-04-27
Pharmaceutical composition for treatment of duchenne muscular dystrophy Grant 6,653,466 - Matsuo November 25, 2	2003-11-25
Medicament for treatment of Duchenne muscular dystrophy Grant 6,653,467 - Matsuo , et al. November 25, 2	2003-11-25
Pharmaceutical composition for treatment of Duchenne muscular dystrophy App 20020055481 - Matsuo, Masafumi ; et al.	2002-05-09
Pharmaceutical composition for treatment of duchenne muscular dystrophy App 20010056077 - Matsuo, Masafumi	2001-12-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.